Expanding the role of injectable collagenase clostridium histolyticum for the treatment of active phase Peyronie's disease

被引:3
作者
Aliperti, Louis A. [1 ]
Mehta, Akanksha [1 ]
机构
[1] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA
关键词
EFFICACY; SAFETY;
D O I
10.21037/tau.2016.12.09
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:114 / 115
页数:2
相关论文
共 5 条
[1]   Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies [J].
Gelbard, Martin ;
Goldstein, Irwin ;
Hellstrom, Wayne J. G. ;
McMahon, Chris G. ;
Smith, Ted ;
Tursi, James ;
Jones, Nigel ;
Kaufman, Gregory J. ;
Carson, Culley C. .
JOURNAL OF UROLOGY, 2013, 190 (01) :199-207
[2]   Bother and Distress Associated with Peyronie's Disease: Validation of the Peyronie's Disease Questionnaire [J].
Hellstrom, Wayne J. G. ;
Feldman, Robert ;
Rosen, Raymond C. ;
Smith, Ted ;
Kaufman, Gregory ;
Tursi, James .
JOURNAL OF UROLOGY, 2013, 190 (02) :627-634
[3]   Peyronie's Disease: AUA Guideline [J].
Nehra, Ajay ;
Alterowitz, Ralph ;
Culkin, Daniel J. ;
Faraday, Martha M. ;
Hakim, Lawrence S. ;
Heidelbaugh, Joel J. ;
Khera, Mohit ;
Kirkby, Erin ;
McVary, Kevin T. ;
Miner, Martin M. ;
Nelson, Christian J. ;
Sadeghi-Nejad, Hossein ;
Seftel, Allen D. ;
Shindel, Alan W. ;
Burnett, Arthur L. .
JOURNAL OF UROLOGY, 2015, 194 (03) :745-753
[4]   Peyronie's Disease and Injectable Collagenase Clostridium histolyticum: Safety, Efficacy, and Improvements in Subjective Symptoms [J].
Yang, Kevin K. ;
Bennett, Nelson .
UROLOGY, 2016, 94 :143-147
[5]  
Ziegelmann MJ, 2016, J UROLOGY, V195, P1051, DOI 10.1016/j.juro.2015.10.065